Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT

Mohammad Naghavi-Behzad; Marianne Vogsen; Rasmus Molgard Vester; Maiken Olsen; Hjalte Oltmann; Poul-Erik Braad; Jon Thor Asmussen; Oke Gerke; Werner Vach; Kristian Kidholm; Annette Raskov Kodahl; Wolfgang Weber; Malene Hildebrandt

Meeting ReportOral - PhysicianPharm

Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT

Mohammad Naghavi-Behzad, Marianne Vogsen, Rasmus Molgard Vester, Maiken Olsen, Hjalte Oltmann, Poul-Erik Braad, Jon Thor Asmussen, Oke Gerke, Werner Vach, Kristian Kidholm, Annette Raskov Kodahl, Wolfgang Weber and Malene Hildebrandt

Journal of Nuclear Medicine May 2021, 62 (supplement 1) 129;

Mohammad Naghavi-Behzad

1Department of Clinical Research University of Southern Denmark Odense Denmark

2Department of Nuclear Medicine Odense University Hospital Odense Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marianne Vogsen

2Department of Nuclear Medicine Odense University Hospital Odense Denmark

3Department of Oncology Odense University Hospital Odense Denmark

1Department of Clinical Research University of Southern Denmark Odense Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rasmus Molgard Vester

2Department of Nuclear Medicine Odense University Hospital Odense Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maiken Olsen

2Department of Nuclear Medicine Odense University Hospital Odense Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hjalte Oltmann

2Department of Nuclear Medicine Odense University Hospital Odense Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Poul-Erik Braad

2Department of Nuclear Medicine Odense University Hospital Odense Denmark

1Department of Clinical Research University of Southern Denmark Odense Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jon Thor Asmussen

1Department of Clinical Research University of Southern Denmark Odense Denmark

4Department of Radiology Odense University Hospital Odense Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Oke Gerke

1Department of Clinical Research University of Southern Denmark Odense Denmark

2Department of Nuclear Medicine Odense University Hospital Odense Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Werner Vach

5Basel Academy for Quality and Research in Medicine Basel Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kristian Kidholm

6Centre for Innovative Medical Technology Odense University Hospital Odense Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Annette Raskov Kodahl

1Department of Clinical Research University of Southern Denmark Odense Denmark

3Department of Oncology Odense University Hospital Odense Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wolfgang Weber

7Department of Nuclear Medicine Technical University of Munich Munich Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Malene Hildebrandt

6Centre for Innovative Medical Technology Odense University Hospital Odense Denmark

2Department of Nuclear Medicine Odense University Hospital Odense Denmark

1Department of Clinical Research University of Southern Denmark Odense Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics

Article Figures & Data

Figures

Download figure
Open in new tab
Download powerpoint

In this issue

Journal of Nuclear Medicine

Vol. 62, Issue supplement 1

May 1, 2021

Table of Contents
Index by author

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT

Journal of Nuclear Medicine May 2021, 62 (supplement 1) 129;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT

Journal of Nuclear Medicine May 2021, 62 (supplement 1) 129;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Info & Metrics

No related articles found.

Google Scholar

Cited By...

No citing articles found.

Google Scholar

Oral - PhysicianPharm

Safety and efficacy of radioligand therapy with ¹⁷⁷lutetium-PSMA-617 within 3 months after ²²³Radium-dichloride
Usefulness of^99mTc SESTAMIBI Scintigraphy in Persistent Hyperparathyroidism after Kidney Transplant
Toll-like receptor 5 in triple-negative breast cancer: a novel reporter for tumor progression

Show more Oral - PhysicianPharm

Advances in PET Imaging for Cancer: Highlights of Clinical Diagnostics in Oncology

A Phase 3 study of ¹⁸F-DCFPyL-PET/CT in Patients with Biochemically Recurrent Prostate Cancer (CONDOR): An Analysis of Disease Detection Rate and Positive Predictive Value (PPV) by Anatomic Region
Ga-68-FAPI for sarcoma imaging: Data from the FAPI-PET prospective observational trial

Show more Advances in PET Imaging for Cancer: Highlights of Clinical Diagnostics in Oncology

Main menu

User menu

Search

Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT

Article Figures & Data

Figures

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Oral - PhysicianPharm

Advances in PET Imaging for Cancer: Highlights of Clinical Diagnostics in Oncology

Similar Articles